BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22170627)

  • 1. A novel aptamer developed for breast cancer cell internalization.
    Zhang K; Sefah K; Tang L; Zhao Z; Zhu G; Ye M; Sun W; Goodison S; Tan W
    ChemMedChem; 2012 Jan; 7(1):79-84. PubMed ID: 22170627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Aptamer-Based Probe for Molecular Subtyping of Breast Cancer.
    Liu M; Wang Z; Tan T; Chen Z; Mou X; Yu X; Deng Y; Lu G; He N
    Theranostics; 2018; 8(20):5772-5783. PubMed ID: 30555580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-specific internalization study of an aptamer from whole cell selection.
    Xiao Z; Shangguan D; Cao Z; Fang X; Tan W
    Chemistry; 2008; 14(6):1769-75. PubMed ID: 18092308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-time imaging of protein internalization using aptamer conjugates.
    Li W; Yang X; Wang K; Tan W; He Y; Guo Q; Tang H; Liu J
    Anal Chem; 2008 Jul; 80(13):5002-8. PubMed ID: 18533682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-SELEX-based selection of aptamers that recognize distinct targets on metastatic colorectal cancer cells.
    Li WM; Bing T; Wei JY; Chen ZZ; Shangguan DH; Fang J
    Biomaterials; 2014 Aug; 35(25):6998-7007. PubMed ID: 24857291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular assembly of an aptamer-drug conjugate for targeted drug delivery to tumor cells.
    Huang YF; Shangguan D; Liu H; Phillips JA; Zhang X; Chen Y; Tan W
    Chembiochem; 2009 Mar; 10(5):862-8. PubMed ID: 19253922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel molecular marker of breast cancer stem cells identified by cell-SELEX method.
    Lu M; Zhou L; Zheng X; Quan Y; Wang X; Zhou X; Ren J
    Cancer Biomark; 2015; 15(2):163-70. PubMed ID: 25519016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro selection of aptamer S1 against MCF-7 human breast cancer cells.
    Zhang WY; Chen HL; Chen QC
    Bioorg Med Chem Lett; 2019 Aug; 29(16):2393-2397. PubMed ID: 31196711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A truncated DNA aptamer with high selectivity for estrogen receptor-positive breast cancer cells.
    Cong Y; Zhang SY; Li HM; Zhong JJ; Zhao W; Tang YJ
    Int J Biol Macromol; 2023 Dec; 252():126450. PubMed ID: 37634779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer.
    Sheikh A; Md S; Kesharwani P
    Biomed Pharmacother; 2022 Feb; 146():112530. PubMed ID: 34915416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aptamers: new arrows to target dendritic cells.
    Ganji A; Varasteh A; Sankian M
    J Drug Target; 2016; 24(1):1-12. PubMed ID: 25950603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
    Zhong Y; Zhao J; Li J; Liao X; Chen F
    Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The DNA aptamer binds stemness-enriched cancer cells in pancreatic cancer.
    Kim YJ; Lee HS; Jung DE; Kim JM; Song SY
    J Mol Recognit; 2017 Apr; 30(4):. PubMed ID: 27891685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of Aptamer-Bound Nanomaterials in Cancer Therapy.
    Zhu L; Zhao J; Guo Z; Liu Y; Chen H; Chen Z; He N
    Biosensors (Basel); 2021 Sep; 11(9):. PubMed ID: 34562934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a fraction collection approach in capillary electrophoresis SELEX for aptamer selection.
    Luo Z; Zhou H; Jiang H; Ou H; Li X; Zhang L
    Analyst; 2015 Apr; 140(8):2664-70. PubMed ID: 25728760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generating aptamers for recognition of virus-infected cells.
    Tang Z; Parekh P; Turner P; Moyer RW; Tan W
    Clin Chem; 2009 Apr; 55(4):813-22. PubMed ID: 19246617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new chemotherapy agent-free theranostic system composed of graphene oxide nano-complex and aptamers for treatment of cancer cells.
    Bahreyni A; Yazdian-Robati R; Hashemitabar S; Ramezani M; Ramezani P; Abnous K; Taghdisi SM
    Int J Pharm; 2017 Jun; 526(1-2):391-399. PubMed ID: 28495579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Selection of a DNA Aptamer by Cell-SELEX as a Molecular Probe for Cervical Cancer Recognition and Imaging.
    Wang J; Gao T; Luo Y; Wang Z; Zhang Y; Zhang Y; Zhang Y; Pei R
    J Mol Evol; 2019 Apr; 87(2-3):72-82. PubMed ID: 30659315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating breast cancer molecular subtypes using a DNA aptamer selected against MCF-7 cells.
    Liu M; Yang T; Chen Z; Wang Z; He N
    Biomater Sci; 2018 Nov; 6(12):3152-3159. PubMed ID: 30349922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering polymeric aptamers for selective cytotoxicity.
    Yang L; Meng L; Zhang X; Chen Y; Zhu G; Liu H; Xiong X; Sefah K; Tan W
    J Am Chem Soc; 2011 Aug; 133(34):13380-6. PubMed ID: 21702469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.